Application of microchip assay system for the measurement of C-reactive protein in human saliva.

In the last decade, saliva has been advocated as a non-invasive alternative to blood as a diagnostic fluid. However, use of saliva has been hindered by the inadequate sensitivity of current methods to detect the lower salivary concentrations of many constituents compared to serum. Furthermore, developments in the areas related to lab-on-a-chip systems for saliva-based point of care diagnostics are complicated by the high viscosity and heterogeneous properties associated with this diagnostic fluid. The biomarker C-reactive protein (CRP) is an acute phase reactant and a well-accepted indicator of inflammation. Numerous clinical studies have established elevated serum CRP as a strong, independent risk factor for the development of cardiovascular disease (CVD). CVD has also been associated with oral infections (i.e. periodontal diseases) and there is evidence that systemic CRP may be a link between the two. Clinical measurements of CRP in serum are currently performed with "high sensitivity" CRP (hsCRP) enzyme-linked immunosorbent assay (ELISA) tests that lack the sensitivity for the detection of this important biomarker in saliva. Because measurement of salivary CRP may represent a novel approach for diagnosing and monitoring chronic inflammatory disease, including CVD and periodontal diseases, the objective of this study was to apply an ultra-sensitive microchip assay system for the measurement of CRP in human saliva. Here, we describe this novel lab-on-a-chip system in its first application for the measurement of CRP in saliva and demonstrate its advantages over the traditional ELISA method. The increased sensitivity of the microchip system (10 pg ml(-1) of CRP with 1000-fold dilution of saliva sample) is attributed to its inherent increased signal to noise ratio, resulting from the higher bead surface area available for antigen/antibody interactions and the high stringency washes associated with this approach. Finally, the microchip assay system was utilized in this study to provide direct experimental evidence that chronic periodontal disease may be associated with higher levels of salivary CRP.

[1]  M. Trevisan,et al.  Periodontal infections contribute to elevated systemic C-reactive protein level. , 2001, Journal of periodontology.

[2]  A. Manz,et al.  Micro total analysis systems. 1. Introduction, theory, and technology. , 2002, Analytical chemistry.

[3]  I. Mandel.  Salivary diagnosis: more than a lick and a promise. , 1993, Journal of the American Dental Association.

[4]  H. Gewurz.  Biology of C-reactive protein and the acute phase response. , 1982, Hospital practice.

[5]  I. Kushner,et al.  Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells. , 1991, Journal of immunology.

[6]  V. Rizzello,et al.  Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease. , 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.

[7]  R. Schasfoort,et al.  TUTORIAL REVIEW , 2001 .

[8]  J. Volanakis,et al.  Human C-reactive protein: expression, structure, and function. , 2001, Molecular immunology.

[9]  C. Streckfus,et al.  Saliva as a diagnostic fluid. , 2002, Oral diseases.

[10]  J B Shear,et al.  Development of multianalyte sensor arrays composed of chemically derivatized polymeric microspheres localized in micromachined cavities. , 2001, Journal of the American Chemical Society.

[11]  J. McDevitt,et al.  Citrate and calcium determination in flavored vodkas using artificial neural networks , 2003 .

[12]  John T McDevitt,et al.  A microchip-based multianalyte assay system for the assessment of cardiac risk. , 2002, Analytical chemistry.

[13]  J. McDevitt,et al.  A multicomponent sensing ensemble in solution: differentiation between structurally similar analytes. , 2003, Angewandte Chemie.

[14]  I. Kushner,et al.  The acute phase response: general aspects. , 1994, Bailliere's clinical rheumatology.

[15]  Andrew D. Ellington,et al.  Solution-based analysis of multiple analytes by a sensor array: toward the development of an electronic tongue , 1998 .

[16]  James P Landers,et al.  Molecular diagnostics on electrophoretic microchips. , 2003, Analytical chemistry.

[17]  D. Malamud,et al.  Detection of Human Immunodeficiency Virus Antibodies in Oral Fluids , 1998, Clinical Diagnostic Laboratory Immunology.

[18]  D. B. Ferguson.  Current Diagnostic Uses of Saliva , 1987, Journal of dental research.

[19]  M. Levine,et al.  Sialochemistry: a diagnostic tool? , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[20]  R. Mathies,et al.  Fully integrated PCR-capillary electrophoresis microsystem for DNA analysis. , 2001, Lab on a chip.

[21]  I. Mandel.  A contemporary view of salivary research. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[22]  Nigel Beard,et al.  Dealing with real samples: sample pre-treatment in microfluidic systems. , 2003, Lab on a chip.

[23]  Prapat Suriyaphol,et al.  Possible Protective Role for C-Reactive Protein in Atherogenesis: Complement Activation by Modified Lipoproteins Halts Before Detrimental Terminal Sequence , 2004, Circulation.

[24]  A. Ellington,et al.  DNA hybridization and discrimination of single-nucleotide mismatches using chip-based microbead arrays. , 2003, Analytical chemistry.

[25]  Yong Chen,et al.  Polymorphism of structural forms of C-reactive protein. , 2002, International journal of molecular medicine.

[26]  A. Manz,et al.  Micro total analysis systems. Recent developments. , 2004, Analytical chemistry.

[27]  D. Kidwell,et al.  Drugs of abuse in saliva: a review. , 1992, Journal of analytical toxicology.

[28]  R. Fair,et al.  An integrated digital microfluidic lab-on-a-chip for clinical diagnostics on human physiological fluids. , 2004, Lab on a chip.

[29]  I. Mandel.  Salivary Diagnosis: Promises, Promises , 1993, Annals of the New York Academy of Sciences.

[30]  J. Gauldie,et al.  Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. , 1990, Molecular biology & medicine.

[31]  A. Berg,et al.  Micro Total Analysis Systems , 1995 .

[32]  H. Baumann,et al.  Interaction of cytokine- and glucocorticoid-response elements of acute-phase plasma protein genes. Importance of glucocorticoid receptor level and cell type for regulation of the elements from rat alpha 1-acid glycoprotein and beta-fibrinogen genes. , 1990, The Journal of biological chemistry.

[33]  S. Depraetere,et al.  Stimulation of CRP secretion in HepG2 cells: Cooperative effect of dexamethasone and interleukin 6 , 1991, Agents and Actions.

[34]  R. Tilvis,et al.  Oral health status, C-reactive protein and mortality--a 10 year follow-up study. , 2003, Gerodontology.

[35]  H. Slavkin.  Toward molecularly based diagnostics for the oral cavity. , 1998, The Journal of the American Dental Association (1939).

[36]  I D Mandel,et al.  The diagnostic uses of saliva. , 1990, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[37]  J. McDevitt,et al.  Differential receptors create patterns diagnostic for ATP and GTP. , 2003, Journal of the American Chemical Society.

[38]  R. Haeckel.  Interpretation of salivary drug concentrations. , 1989, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[39]  M. Pepys,et al.  C-reactive protein and atherothrombosis. , 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.

[40]  M. Navazesh,et al.  Methods for Collecting Saliva , 1993, Annals of the New York Academy of Sciences.

[41]  C. Mold,et al.  C-reactive protein and the acute phase response. , 1982, Advances in internal medicine.

[42]  G. Ciliberto,et al.  Dual control of C‐reactive protein gene expression by interleukin‐1 and interleukin‐6. , 1989, The EMBO journal.

[43]  Pekka Nuutinen,et al.  Dental infections and serum inflammatory markers in patients with and without severe heart disease. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[44]  P. Ridker.  High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. , 2004, American heart journal.

[45]  J B Shear,et al.  Characterization of multicomponent monosaccharide solutions using an enzyme-based sensor array. , 2001, Analytical biochemistry.

[46]  P. Ridker,et al.  C-reactive protein, inflammation, and coronary risk. , 2003, Cardiology clinics.

[47]  W. Koenig.  C-reactive protein: risk assessment in the primary prevention of atherosclerotic disease. Has the time come for including it in the risk profile? , 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.

[48]  Elisabeth Verpoorte,et al.  Beads and chips: new recipes for analysis. , 2003, Lab on a chip.

[49]  G. Ciliberto,et al.  Regulation of the human C-reactive protein gene, a major marker of inflammation and cancer. , 1990, Molecular biology & medicine.

[50]  Ryuji Koyama,et al.  Counting and sizing of particles and particle agglomerates in a microfluidic device using laser light scattering: application to a particle-enhanced immunoassay. , 2003, Lab on a chip.